Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
Antibody Actions01:26

Antibody Actions

3.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.1K
Affinity and Avidity01:41

Affinity and Avidity

39.4K
Overview
39.4K
Humoral Immune Responses01:36

Humoral Immune Responses

84.5K
Overview
84.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

14.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.7K
Antibody Structure01:10

Antibody Structure

66.0K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The B cell receptor-mTOR signaling axis restricts the accumulation of lung tissue-resident memory B cells after influenza infection.

Science immunology·2026
Same author

Intestinal intraepithelial lymphocyte migration and tissue homeostasis are dictated by Gα13.

bioRxiv : the preprint server for biology·2026
Same author

ABCC1 protects skin dendritic cells from FITC-induced toxicity by efflux and extracellular glutathione buffering.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine.

The Journal of experimental medicine·2025
Same author

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

bioRxiv : the preprint server for biology·2025
Same author

Author Correction: EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells.

Nature·2025
Same journal

Erratum for the Research Article "Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer".

Science immunology·2026
Same journal

Langerhans cell control of early-life dermal lymphatic development shapes adult immunity.

Science immunology·2026
Same journal

T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

Science immunology·2026
Same journal

CXCL16-mediated recruitment of γδ T cells to the brain reduces sociability in mice.

Science immunology·2026
Same journal

Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes.

Science immunology·2026
Same journal

Bacterial infection reshapes monocyte and macrophage ontogeny at the CNS borders.

Science immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.6K

Interfer'n with antibody responses.

Brian J Laidlaw1, Jason G Cyster2

  • 1Department of Microbiology and Immunology and Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA 94143, USA.

Science Immunology
|August 8, 2017
PubMed
Summary
This summary is machine-generated.

Type I interferon critically impedes the development of neutralizing antibodies during chronic infections. This immune response blockade hinders effective antibody generation against persistent pathogens.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

8.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.6K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

8.2K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Virology

Background:

  • Chronic infections pose significant challenges to the immune system.
  • Neutralizing antibodies are crucial for pathogen clearance and long-term immunity.
  • Type I interferons are key antiviral cytokines with complex roles in immunity.

Purpose of the Study:

  • To investigate the impact of Type I interferon signaling on antibody generation during chronic infection.
  • To elucidate the mechanisms by which Type I interferon affects neutralizing antibody production.

Main Methods:

  • Utilized a mouse model of chronic viral infection.
  • Administered Type I interferon or placebo.
  • Assessed antibody titers and neutralizing capacity via ELISA and viral neutralization assays.
  • Analyzed immune cell populations and cytokine profiles.

Main Results:

  • Type I interferon treatment significantly reduced the generation of neutralizing antibodies.
  • A decrease in antibody-producing plasma cells was observed in interferon-treated animals.
  • Interferon signaling pathways were found to be active in B cells during chronic infection.

Conclusions:

  • Type I interferon signaling actively suppresses the development of effective neutralizing antibody responses in chronic infections.
  • Targeting Type I interferon pathways may be a therapeutic strategy to enhance antibody immunity during persistent infections.